Enzyme replacement therapy to treat alpha-mannosidosis
The EMA has recommended granting a marketing authorisation in the EU for Lamzede a long-term enzyme replacement therapy for alpha-mannosidosis...
List view / Grid view
The EMA has recommended granting a marketing authorisation in the EU for Lamzede a long-term enzyme replacement therapy for alpha-mannosidosis...
A drug used to treat Hepatitis C effectively protected and rescued neural cells infected by the Zika virus...
A drug used to treat seizures may effectively treat the movement symptoms in people with dementia with Lewy bodies without causing additional psychiatric symptoms...
Treatment with a pharmaceutical formulation of cannabidiol alongside other anti-epilepsy treatments helped to reduce the number of drop seizures in people with Lennox-Gastaut syndrome...
Researchers find that vitamin D supplements could help to ease painful Irritable Bowel Syndrome symptoms...
Researchers have developed a universal vaccine to combat influenza A viruses that produces long-lasting immunity...
Addition of hydroxyurea to current chemotherapy significantly improved survival in animal models of glioblastoma...
The European Commission has granted marketing authorisation for Mvasi for the treatment of certain types of cancer...
An international research team has conducted successful phase II clinical tests of a new anti-malaria medication...
From the early use of Hansch parameters and Topliss Trees to today’s computational structure–activity techniques, medicinal chemists have long sought to rationalise drug design to find the quickest and most resource-efficient route to market. But while modern strategies are more reliant on statistical algorithms and vast data libraries, these founding…
The FDA has granted Breakthrough Therapy designation to Promacta for use in combination with standard immunosuppressive therapy for severe aplastic anaemia...
Clinical trial results provide evidence that using the generic skin cream fluorouacil 5 percent for two to four weeks may reduce the risk of SCC...
Kisqali receives breakthrough therapy designation for initial endocrine-based treatment of pre- or perimenopausal women with HR+/HER2- advanced or metastatic breast cancer...
At least some degree of solubility in water is necessary for active ingredients in pharmaceutical products to be effective in vivo. However, as efforts to discover and synthesise new active ingredients are pursued by industrial and academic medicinal chemists, achieving sufficient aqueous solubility can often be a significant limitation to…
A drug developed for diabetes could be used to treat Alzheimer's after scientists discover it significantly reversed memory loss in mice through a triple method of action...